V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320004883 | 320003279 | 1.64 | null | Curative (C) | 2017-05-25 | 2017-06-22 | Cisplatin | N | Y | 320014435 | CISPLATIN |
| 320004884 | 320003280 | 1.74 | 96 | Palliative (P) | 2014-02-12 | 2014-03-11 | GEMCARBO | 02 | N | 320014441 | GEMCARBO |
| 320004885 | 320003281 | 1.64 | 108.5 | Palliative (P) | 2017-03-18 | 2017-03-18 | Carboplatin + Liposomal Doxorubicin | null | N | 320014444 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004886 | 320003282 | 1.9 | 95 | Neo-adjuvant (N) | 2015-01-29 | 2015-06-04 | null | 02 | N | 320014444 | NOT MATCHED |
| 320004887 | 320003284 | 1.66 | 105.2 | Palliative (P) | 2017-08-11 | 2017-09-02 | Carboplatin + Liposomal Doxorubicin | Y | N | 320014452 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004888 | 320003286 | 1.64 | 30.6 | Adjuvant (A) | 2018-01-09 | 2018-02-21 | GEMCARBO | 02 | N | 320014458 | GEMCARBO |
| 320004889 | 320003286 | 1.71 | 83 | Palliative (P) | 2017-10-13 | 2017-10-29 | CETUXIMAB | N | Y | 320014458 | CETUXIMAB |
| 320004890 | 320003287 | 1.48 | 77.2 | Palliative (P) | 2015-12-30 | 2016-01-28 | GEMCARBO | N | N | 320014466 | GEMCARBO |
| 320004891 | 320003287 | 1.64 | 79.7 | Adjuvant (A) | 2017-04-24 | 2017-05-16 | CNS LGG 2004 03 con vinc +cisplatin | 02 | Y | 320014466 | NOT MATCHED |
| 320004892 | 320003287 | 1.67 | 75 | Adjuvant (A) | 2016-09-20 | 2016-09-25 | Liposomal Doxorubicin (Caelyx) | N | Y | 320014466 | LIPOSOMAL DOXORUBICIN |
| 320004893 | 320003290 | 1.87 | 55 | Palliative (P) | 2016-08-31 | 2016-09-03 | Liposomal Doxorubicin 40mg/m2 | 02 | Y | 320014488 | LIPOSOMAL DOXORUBICIN |
| 320004894 | 320003291 | 1.75 | 88.7 | Palliative (P) | 2018-12-03 | 2018-12-04 | GemCarbo Days 1+8 | N | N | 320014488 | GEMCARBO |
| 320004895 | 320003292 | 1.76 | 81 | Palliative (P) | 2017-05-01 | 2017-05-07 | Trial Unspecified | N | Y | 320014507 | TRIAL |
| 320004896 | 320003293 | 1.84 | 72 | Disease modification (D) | 2016-08-13 | 2017-06-09 | CARBOPLATIN + GEMCITABINE | N | Y | 320014510 | GEMCARBO |
| 320004897 | 320003294 | 1.73 | 53 | Adjuvant (A) | 2016-05-05 | 2016-07-11 | Cisplatin 100 + RT(H&N) 1 day | N | N | 320014510 | CISPLATIN + RT |
| 320004898 | 320003295 | 1.65 | 59.2 | Palliative (P) | 2017-02-01 | 2017-05-13 | Cetuximab 7 day (>Cycle 2) | 2 | N | 320014517 | CETUXIMAB |
| 320004899 | 320003295 | 1.68 | 83 | Palliative (P) | 2016-11-26 | 2016-11-27 | Liposomal Doxorubicin (Caelyx) | N | N | 320014517 | LIPOSOMAL DOXORUBICIN |
| 320004900 | 320003295 | null | 64.2 | Palliative (P) | 2016-12-20 | 2016-12-20 | CISPLATIN + FLUOROURACIL | N | N | 320014517 | CISPLATIN + FLUOROURACIL |
| 320004901 | 320003296 | 1.9 | 76.7 | Palliative (P) | 2016-06-03 | 2016-06-08 | Cisplatin +Fluorouracil (3 wk) | N | N | 320014542 | CISPLATIN + FLUOROURACIL |
| 320004902 | 320003297 | 1.7 | 88.5 | Palliative (P) | 2015-04-16 | 2015-04-16 | LUX TRIAL | 02 | N | 320014544 | TRIAL |
| 320004903 | 320003297 | 1.67 | 51 | null | 2017-05-14 | 2017-05-14 | GemCarbo Days 1+8 | 02 | Y | 320014544 | GEMCARBO |
| 320004904 | 320006544 | 1.72 | 77 | Adjuvant (A) | 2017-06-04 | 2017-06-19 | Cisplatin + Radiotherapy | N | N | 320014560 | CISPLATIN + RT |
| 320004905 | 320003298 | null | 72 | Neo-adjuvant (N) | 2016-07-12 | 2016-07-20 | GemCarbo Days 1+8 | N | N | 320014561 | GEMCARBO |
| 320004906 | 320005502 | 1.74 | 94 | null | 2017-04-06 | 2017-04-28 | Carboplatin + Liposomal Doxorubicin | 02 | N | 320014561 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004907 | 320005502 | 1.51 | 44.6 | Palliative (P) | 2015-08-17 | 2015-08-17 | GemCarbo Days 1+8 | N | N | 320014561 | GEMCARBO |
| 320004908 | 320005502 | 1.63 | 53.6 | Palliative (P) | 2015-08-19 | 2015-08-19 | GemCarbo Days 1+8 | 01 | N | 320014561 | GEMCARBO |
| 320004909 | 320003300 | 1.53 | 97.9 | Palliative (P) | 2015-08-13 | 2015-08-22 | GemCarbo Days 1+8 | N | N | 320014577 | GEMCARBO |
| 320004910 | 320005503 | 1.56 | 65.2 | Palliative (P) | 2013-02-19 | 2013-05-24 | CISPLATIN + FLUOROURACIL | 02 | N | 320014578 | CISPLATIN + FLUOROURACIL |
| 320004911 | 320005503 | 1.7 | 63 | Palliative (P) | 2015-12-02 | 2016-02-22 | GemCarbo Days 1+8 | N | null | 320014578 | GEMCARBO |
| 320004912 | 320003302 | 1.67 | 96 | null | 2014-02-26 | 2014-04-02 | Cisplatin | 2 | N | 320014582 | CISPLATIN |
| 320004913 | 320003306 | 1.66 | null | Adjuvant (A) | 2018-05-06 | 2018-05-07 | EW EuroEwing 2012 Arm B VC | 02 | N | 320014587 | NOT MATCHED |
| 320004914 | 320003307 | 1.86 | null | Palliative (P) | 2014-04-02 | 2014-04-29 | GEMCARBO | N | N | 320014588 | GEMCARBO |
| 320004915 | 320003308 | 1.64 | 50 | Palliative (P) | 2013-10-03 | 2013-10-10 | Liposomal Doxorubicin (Caelyx) | 2 | N | 320014590 | LIPOSOMAL DOXORUBICIN |
| 320004916 | 320003311 | 1.68 | 77.4 | Palliative (P) | 2018-06-29 | 2018-06-29 | Carboplatin + Liposomal Doxorubicin | N | Y | 320014590 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004917 | 320003313 | 1.77 | 88.5 | Neo-adjuvant (N) | 2016-04-23 | 2016-04-23 | CISPLATIN + FLUOROURACIL | N | N | 320014592 | CISPLATIN + FLUOROURACIL |
| 320004918 | 320003314 | 1.63 | 65.8 | Adjuvant (A) | null | 2017-11-09 | Cisplatin + Radiotherapy | N | Y | 320014596 | CISPLATIN + RT |
| 320004919 | 320003315 | 1.7 | 72.3 | Curative (C) | 2014-11-03 | 2015-01-27 | Cisplatin | 02 | N | 320014599 | CISPLATIN |
| 320004920 | 320003315 | 1.64 | 55.4 | Palliative (P) | 2017-07-15 | 2017-07-22 | GEMCARBO | N | Y | 320014599 | GEMCARBO |
| 320004921 | 320003316 | 1.6 | 57.1 | Palliative (P) | 2018-01-01 | 2018-01-29 | CARBOPLATIN + GEMCITABINE | N | Y | 320014601 | GEMCARBO |
| 320004922 | 320003316 | 1.62 | 53.6 | Curative (C) | 2013-04-17 | 2013-04-20 | Trial Unspecified | 02 | N | 320014601 | TRIAL |
| 320004923 | 320003316 | 1.7 | null | Curative (C) | null | 2016-06-22 | Cisplatin + Radiotherapy | N | N | 320014601 | CISPLATIN + RT |
| 320004924 | 320003317 | 1.52 | 82.3 | null | 2018-03-13 | 2018-03-15 | GemCarbo Days 1+8 | 2 | null | 320014628 | GEMCARBO |
| 320004925 | 320003318 | 1.66 | 44.4 | Palliative (P) | 2017-09-30 | 2017-10-07 | Cisplatin +Fluorouracil (3 wk) | N | null | 320014635 | CISPLATIN + FLUOROURACIL |
| 320004926 | 320003319 | 1.61 | 62.5 | Neo-adjuvant (N) | 2014-03-23 | 2014-04-19 | CNS LGG 2004 03 cons vinc + carbo | N | null | 320014641 | NOT MATCHED |
| 320004927 | 320003319 | 1.66 | 76.8 | Not known (9) | 2016-05-02 | 2016-05-02 | CISPLATIN + RT | 02 | Y | 320014641 | CISPLATIN + RT |
| 320004928 | 320003320 | 1.74 | 69.5 | Palliative (P) | 2017-09-08 | 2018-03-12 | Carboplatin + Liposomal Doxorubicin | N | Y | 320014653 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004929 | 320006549 | 1.69 | 104.4 | Palliative (P) | 2015-04-25 | 2015-04-26 | Cetuximab 7 day (>Cycle 2) | N | N | 320014660 | CETUXIMAB |
| 320004930 | 320003321 | 1.64 | 52.4 | Adjuvant (A) | 2015-08-24 | 2015-09-21 | CNS LGG | null | Y | 320014664 | NOT MATCHED |
| 320004931 | 320003321 | 1.69 | 87 | Adjuvant (A) | 2018-02-25 | 2018-03-20 | Cetuximab 7 day (>Cycle 2) | 02 | null | 320014664 | CETUXIMAB |
| 320004932 | 320003322 | 1.6 | null | Curative (C) | 2014-11-06 | 2014-11-20 | Cisplatin + Radiotherapy | N | null | 320014678 | CISPLATIN + RT |